Sound waves aim to unlock Brain's secrets in healthy volunteers
NCT ID NCT07508722
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study explores how focused ultrasound can change brain activity in healthy adults. Researchers will send sound waves through the skull to the visual and hearing parts of the brain to see what people perceive. The goal is to find the best settings for future treatments of conditions like chronic pain and depression. Twenty healthy volunteers aged 21-55 will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 55 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
The inclusion criteria for this study are as follows: 1. Healthy male and female adults aged 21-55. 2. No contraindications to magnetic resonance imaging (MRI) scans, such as claustrophobia. The exclusion criteria for this study are as follows: 1. History of major medical, neurological (including peripheral nerve disease) or psychiatric illness. 2. History of vsacular conditions, predisposition to hemorrhage, or blood thinner medications 3. History of head trauma with loss of consciousness. 4. Use of sedatives, analgesics and agents that affect brain function. 5. Contraindications for exposure to the high magnetic field of MRI imaging 6. History of skin irritation from acoustic coupling materials such as a water-based gel and polyvinyl alcohol (PVA; a common household plastic bag material). 7. Vulnerable subpopulations (pregnant women, children, institutionalized individuals). 8. Use of excessive alcohol (e.g., no more than one can of beer or glass of wine) or strenuous exercise (e.g., no more than daily routine) on the day of the visit
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteers are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Massachusetts Institute of Technology - McGovern Institute for Brain Research
Cambridge, Massachusetts, 02139, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Comparative effects of three breathing techniques on heart rate variability, attention, reaction time, and anxiety in healthy adults: a randomized controlled trial
- An Open-Label phase 1 study to assess the safety, tolerability, and pharmacokinetics of a single dose of a new tablet formulation of TRTL-729 in healthy adults
- A phase 2b, randomized, placebo-controlled, observer-blind study in adults 60 years of age and older to evaluate the efficacy, safety, and immunogenicity of a bivalent protein vaccine candidate against respiratory syncytial virus (RSV) and human metapneumovirus (HMPV)
- THERMOS-LUNCH: effects of meals differing in nutritional quality and environmental footprint on postprandial metabolism, Diet-Induced thermogenesis, respiratory quotient, satiety, and hydration status in healthy young men
- Phase i clinical study, open-label, randomized, parallel to evaluate the safety of the 200 mg dexibuprofen following single and multiple dose oral administration in healthy participants of both sexes under fasting and fed conditions.
- Can a copycat humira match the original?